Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related LHCG
Top 4 Stocks In The Home Health Care Industry With The Highest Operating Margin
Top Performing Industries For May 7, 2015
Related GEVA
Synageva BioPharma Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Japan
Oppenheimer Downgrades Dyax
Insider Wisdom And The New Medicine (Seeking Alpha)

Analysts at Deutsche Bank downgraded LHC Group (NASDAQ: LHCG) from “buy” to “hold.” The target price for LHC Group is set to $23. LHC Group's shares closed at $23.36 yesterday.

Analysts at JP Morgan downgraded Synageva BioPharma (NASDAQ: GEVA) from “overweight” to “neutral.” The target price for Synageva BioPharma has been lowered from $57 to $50. Synageva BioPharma's shares closed at $45.79 yesterday.

Analysts at Canaccord Genuity downgraded Rent-A-Center (NASDAQ: RCII) from “buy” to “hold.” The target price for Rent-A-Center has been lowered from $42.00 to $37.00. Rent-A-Center's shares closed at $35.80 yesterday.

McNicoll Lewis Vlak downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from “buy” to “hold.” The target price for Transcept Pharmaceuticals is set to $3. Transcept Pharmaceuticals' shares closed at $3.09 yesterday.

Latest Ratings for LHCG

DateFirmActionFromTo
Feb 2015Credit SuisseMaintainsOutperform
Dec 2014Credit SuisseUpgradesUnderperformOutperform
Nov 2014BairdUpgradesUnderperformNeutral

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (LHCG + GEVA)

Around the Web, We're Loving...